Next Article in Journal
A Water-Stable Organic-Inorganic Hybrid Perovskite for Solar Cells by Inorganic Passivation
Next Article in Special Issue
Solvent-Mediated Polymorphic Transformation of Famoxadone from Form II to Form I in Several Mixed Solvent Systems
Previous Article in Journal
High-Temperature Cooperative Spin Crossover Transitions and Single-Crystal Reflection Spectra of [FeIII(qsal)2](CH3OSO3) and Related Compounds
Previous Article in Special Issue
Melting Diagrams of Adefovir Dipivoxil and Dicarboxylic Acids: An Approach to Assess Cocrystal Compositions
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

(2E)-2-[1-(1,3-Benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-N-(2-chlorophenyl)hydrazine carboxamide: Synthesis, X-ray Structure, Hirshfeld Surface Analysis, DFT Calculations, Molecular Docking and Antifungal Profile

by
Reem I. Al-Wabli
1,*,
Alwah R. Al-Ghamdi
1,
Suchindra Amma Vijayakumar Aswathy
2,
Hazem A. Ghabbour
3,
Mohamed H. Al-Agamy
4,5,
Issac Hubert Joe
2 and
Mohamed I. Attia
1,6,*
1
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
2
Center for Molecular Biophysics Research, Mar Ivanios College, Nalanchira, Thiruvanthapuram 695015, India
3
Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt
4
Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
5
Microbiology and Immunology Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt
6
Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre (ID: 60014618), El Bohooth Street, Dokki, Giza 12622, Egypt
*
Authors to whom correspondence should be addressed.
Crystals 2019, 9(2), 82; https://doi.org/10.3390/cryst9020082
Submission received: 3 January 2019 / Revised: 26 January 2019 / Accepted: 29 January 2019 / Published: 4 February 2019
(This article belongs to the Special Issue Pharmaceutical Crystals)

Abstract

:
Life-threatening fungal infections accounts for a major global health burden especially for individuals suffering from cancer, acquired immune deficiency syndrome (AIDS), or autoimmune diseases. (2E)-2-[1-(1,3-Benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-N-(2-chlorophenyl)hydrazinecarboxamide has been synthesized and characterized using various spectroscopic tools to be evaluated as a new antifungal agent. The (E)-configuration of the imine moiety of the title molecule has been unequivocally identified with the aid of single crystal X-ray analysis. The molecular structure of compound 4 was crystallized in the monoclinic, P21/c, a = 8.7780 (6) Å, b = 20.5417 (15) Å, c = 11.0793 (9) Å, β = 100.774 (2)°, V = 1962.5 (3) Å3, and Z = 4. Density functional theory computations have thoroughly explored the electronic characteristics of the title molecule. Moreover, molecular docking studies and Hirshfeld surface analysis were also executed on the title compound 4. The in vitro antifungal potential of the target compound was examined against four different fungal strains.

1. Introduction

The dramatic increase in the morbidity due to life-threatening fungal infections accounts for a major health burden worldwide, particularly for those individuals suffering from cancer, AIDS, or autoimmune diseases [1,2,3]. The presence of few drug targets in the eukaryotic fungal cells that are not shared with human cells limits the availability of selective antifungal agents, as compared with the anti-bacterials [4]. The emergence of resistance to the available antifungal agents as well as their serious side effects led to the necessity for the search for new alternative antifungal therapies [5].
Imidazole and/or triazole moieties constitute the core pharmacophore part of most azoles, which are used as a first-line treatment for various fungal infections [6]. Azoles inhibit competitively the sterol biosynthesis via inhibition of fungal lanosterol 14α-demethylase (CYP51) leading to a hindering of the normal fungal growth [7]. The presence of two carbons linking the azole pharmacophore part and an aromatic residue is a common feature in the available antifungal azoles. Whereas, the reported antifungal candidates bearing a propyl bridige between the aromatic moiety and the azole fragment are limited [8,9,10].
Semicarbazones are formally derived from the condensation of certain semicarbazide with the appropriate aldehydes or ketones. While semicarbazones have received less attention than their respective thiosemicarbazones, they became versatile ligands and drawn the attention of a number of researchers in the scientific community during the last fifteen years. Semicarbazones have the ability to coordinate with various metal ions and form complexes due to the existence of oxygen and nitrogen donor atoms in their core structure. In addition, they mostly occur in the keto form in the solid state, while they exhibit a keto-enol tautomerism in the solution state [11]. Semicarbazones displayed significant antibacterial, anticonvulsant, antioxidant, and antifungal activities and their structures can be further elaborated to prepare various bioactive heterocyclic compounds [12,13]. Moreover, metal complexes of semicarbazones exhibited a broad spectrum bioactivities like the activities toward smallpox, protozoa, influenza, trypanosomiasis, certain kinds of tumors, malaria, and fungi [14].
In addition, literature search exposed that benzodioxole fragment occurs in a large number of biologically active molecules including antimicrobials [15,16,17].
In a continuation of our efforts to obtain new potent antifungal compounds [18,19,20,21,22], we were inspired to design and synthesize (2E)-2-[1-(1,3-benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-N-(2-chlorophenyl)hydrazinecarboxamide to be examined as a new antifungal agent. The title compound comprises three pharmacophore parts, namely imidazole, semicarbazone, and benzodioxole with a three-carbon bridge separating benzodioxole and imidazole fragments with the aim to get new potent drug-like antifungal hybrid. Single crystal X-ray analysis and different spectroscopic techniques assured the assigned chemical structure of the title compound as well as the (E)-configuration of its imine functionality. In addition, the electronic characters and molecular geometry of the title molecule were explored with the aid of density functional theory (DFT) computations. Molecular docking simulations and Hirshfeld surface analysis were also executed for the title compound 4. The in vitro antifungal profile of the target compound was examined against four different fungal strains.

2. Experimental

2.1. General

Gallenkamp melting point apparatus was harnessed to measure melting point of compound 4 and it is uncorrected. Nuclear magnetic resonance (NMR) measurements were executed in DMSO-d6 with the aid of Bruker NMR spectrometer at 500 MHz for 1H and 125.76 MHz for 13C at the Research Center, College of Pharmacy, King Saud University, Saudi Arabia. δ-values (ppm) were used to represent chemical shifts in relation to tetramethylsilane (TMS) as an internal standard. Mass spectrum of compound 4 was recorded using Agilent Quadrupole 6120 LC/MS (Agilent Technologies, Palo Alto, CA, USA) implemented with ESI (Electrospray ionization) source. Silica gel precoated aluminum thin layer chromatography plates with fluorescent indicator at 254 nm were secured from Merck (Darmstadt, Germany) and illumination with UV light source (254 nm) accomplished visualization.

2.2. Synthesis

Synthesis of (2E)-2-[1-(1,3-benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-N-(2-chloro phenyl)hydrazinecarboxamide (4)

Few drops of glacial acetic acid were added to a stirred reaction mixture containing ketone 3 (0.24 g, 10 mmol) and N-(2-chlorophenyl)hydrazinecarboxamide (1.86 g, 10 mmol) [23], in absolute ethyl alcohol (15 mL) and stirring was continued atambient temperature for 18 h. Ethyl alcohol was removed under vacuum and the residue was purified by re-crystallization from ethyl alcohol to afford the corresponding semicarbazones 4 as colorless crystals suitable for X-ray analysis. Yield 0.51 g (51%); white powder m.p. 163–165 °C; IR (KBr): ν (cm−1) 3676 (NH), 3018, 2902, 1753 (C=O), 1508 (C=N), 1442, 1352, 754; 1H-NMR (DMSO-d6): δ (ppm) 3.29 (t, J = 7.0 Hz, 2H, –CH2–CH2–N), 4.11 (t, J = 7.0 Hz, 2H, –CH2–CH2–N), 6.08 (s, 2H, -O-CH2-O-), 6.86 (s, 1H, –N–CH=CH–N=), 6.94 (d, J = 8.0 Hz, 1H, Ar–H), 7.10 (t, J = 7.5 Hz, 1H, Ar–H), 7.25 (d, J = 8.5 Hz, 1H, Ar–H), 7.27 (s, 1H, –N–CH=CH–N= ), 7.36 (t, J = 7.5 Hz, 1H, Ar-H), 7.41 (s, 1H, Ar-H), 7.51 (d, J = 7.5 Hz, 1H, Ar-H), 7.63 (s, 1H, –N–CH=N–), 8.25 (d,J = 7.5 Hz, 1H, Ar-H), 9.12 (s, 1H, NH), 10.57 (s, 1H, NH); 13C-NMR (DMSO-d6): δ(ppm) 28.9 (C-2′), 42.8 (C-3′), 101.9 (–O–CH2–O–),106.3, 108.5, (Ar–CH), 119.9 (C-5″), 121.1, 121.2, 122.9, 124.3, 128.4, 128.7, 129.6, 131.3, 135.7 (Ar-CH, Ar–C, C-4″), 137.8 (C-2″), 145.9, 148.3, 148.7, 153.4 (Ar–C, C=O, C=N); MS m/z (ESI): 412.1 [M + H]+, 413.0 [(M + 1) + H]+, and 414.1 [(M + 2) + H]+.

2.3. Crystal Structure Determination

Single crystals of the title compound 4 were achieved via slow evaporation of the ethyl alcohol solution of the pure compound at ambient temperature. Bruker APEX-II D8 Venture area diffractometer (Bruker, Billerica, MA, USA) implemented with graphite monochromatic Mo Kαradiation, λ = 0.71073 Å at 293 (2) K, was employed for data collection. Bruker SAINT was harnessed for data reduction and cell refinement and SHELXT [24] was utilized for structure solving. Full-matrix least-square technique was utilized for final refinement with the aid of anisotropic thermal data for non-hydrogen atoms on F. CCDC 1,875,003 contains the supplementary crystallographic data for compound 4 can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.

2.4. Quantum Chemical Calculations

Quantum mechanical methods helped by the functional B3LYP/6-311+G were used to obtain the vibrational wavenumbers of the semicarbazone 4 and to optimizeits structure [25]. The theoretical investigations of the semicarbazone 4 were carried out with the aid of Gaussian 09W software [26]. The exchange and correlation functions embedded in the software with the occurrence of the density functional theory (DFT) are vital to get results closer to the experimental data. The distribution of assignments of the simulated wavenumbers were evaluated with the aid of vibrational energy distribution analysis (VEDA) 4 program [27].Crystal Explorer 3.1 was utilized to generate fingerprint plots and Hirshfeld surface map of the semicarbazone 4 [28]. NBO 3.1 program supported natural hybrid calculations, natural populations, and natural bonding orbital investigations [29].

2.5. Antifungal Activity

The MICs of the semicarbazone 4 towards various fungal strains were inspected according to literature method [20].

3. Results and Discussion

3.1. Chemistry

The synthetic procedure to prepare the target compound 4 is decorated in Scheme 1. The ketone 3 [19] was successfully obtained according to the previously reported method using acetophenone derivative 1 as a starting material. Subsequently, the semicarbazide N-(2-chlorophenyl)hydrazinecarboxamide [23] was allowed to react with compound 3 to yield the target semicarbazones 4 in an acceptable yield.

3.2. Crystal Structure of the Semicarbazone 4

In compound 4, C20H18ClN5O3, the crystallographic information and refinement data are presented in Table 1. Table 2 illustrates the chosen bond angles and bond lengths. Figure 1 displayed the asymmetric unit which contains one independent molecule. All the bond angles and bond lengths occur in normal ranges [30]. The molecules are packed together in the crystal structure by one classical hydrogen bond and three non-classical hydrogen bonds, as presented in Figure 2 and Table 3. The 1,3-benzodioxole plane makes dihedral angles of 16.91° and 52.91° with a chlorophenyl ring and imidazole ring, respectively.

3.3. Structural Geometry Analysis

The geometry of the semicarbazone 4 was optimized with the aid of DFT theory at B3LYP/6-311++G (d,p) level of basis set by Gaussian 09 program package. The atom numbering scheme is displayed in Figure 3. No constraints on the bond lengths, bond angles or dihedral angles were observed in the calculations and all atoms were free to optimize. Table 4 illustrates the relevant optimized geometrical parameters for the semicarbazone 4 along with its experimental values. There is a difference in values from crystallographic data which might be arise from the fact that theoretical results belong to gaseous phase (isolated molecule), whereas the experimental results belong to solid phase. A statistical correlation graph showing the gaseous and solid phase bond lengths is depicted in Figure S1 with R2 value of 0.97233.
The title molecule bears a chlorophenyl moiety connected with a benzodioxole ring through a hydrazinecarboxamide bridge. Connection was extended to theimidazole ring through an ethylene group. Computational geometry optimization of the title molecule revealed that the global energy minimum for the non-planar structure was obtained by 1732.9189 Hartree. The calculated bond lengths of C3–H11, C2–H10, C5–H12 of the benzodioxole ring are 1.0816, 1.0822, and 1.0811 Å, respectively. The shortening of C5–H12 might beowing to the presence of intramolecular C5–H12N30 hydrogen bonding and it is significantly shorter than the van der Waals radii (2.4104 Å).
The angle of 95.83° between C5–H12N30 is also within the angle limit manifesting C–HN intramolecular hydrogen bonding. The C–N bond lengths C32–N31 (1.4042 Å) and C32–N33 (1.3875 Å) are shorter than the normal C–N bond length of 1.480 Å. This discrepancy could be attributed to the conjugation of Pi-type electrons of the carbonyl group and nitrogen atom, allowing the electrons to smear out along the C–N bond. Table 4 displayed bond lengths of C3–C4 and C4–C5 in the benzodioxole ring as well as C34–C35, C34–C39 in the chlorophenyl ring which are significantly longer than the other C–C bond lengths in both rings. This is due to the intramolecular charge transfer (ICT) between two rings through hydrazinecarboxamide moiety. DFT calculations indicates a decrease in the endocycyclic angles C3–C4–C5 and C35–C34–C39 by 0.76° and 2.42°, respectively, from the normal endocyclic angle of 120° supporting intramolecular charge transfer interactions.

3.4. Natural Bond Orbital Analysis

The NBO calculations were performed using the NBO 3.1 program [29] as implemented in the Gaussian 09 package at the DFT level. It is proved that NBO analysis is an efficient approach for the chemical interpretation of hyperconjugative interactions within the molecule. Additionally, it can be used to explain the electron density transfer (EDT) from the filled lone electron pairs of n(Y) of the “Lewis base“ Y into the unfilled antibond σ*(X–H) of the “Lewis acid” X–H in X–HY hydrogen bonding systems. In addition, NBO analysis can be exploited to elucidate inter and intramolecular hydrogen bonding as well as intermolecular charge transfer in organic molecules.
The intramolecular C–HN hydrogen bonding was formed due to the overlap between n1(O) and σ*C–H which results in intramolecular charge transfer (ICT) causing stabilization of the system. These interactions lead to an increased electron density of the C–H antibonding orbital, which strengthens the C–H bond. In addition, NBO analyses confirmed C5–H12N30 intramolecular hydrogen bonding formed by the overlap between a lone pair n1(N30) and σ*C5–H12 antibonding orbitals with stabilization energy of 4.40 kcal/mol. Other important interactions are displayed in Table 5.

3.5. Natural Population Analysis

Atomic charges and electron distribution within a molecule can be effectively calculated with the aid of natural population analysis (NPA) [31]. Figure 4 clearly illustrates the atomic charges of the semicarbazone 4 obtained by NPA. The hydrogen atoms of the semicarbazone 4 exhibited net positive charges. The atoms H45 and H47 manifested more positive charge than the other hydrogen atoms owing to their connection to nitrogen atoms. Among the hydrogen atoms of the chlorophenyl and benzodioxole ring, H12 showed the highest positive charge, being involved in C–H⋅⋅⋅N intramolecular hydrogen bonding. Moreover, the all carbon atoms manifested negative charges except C1, C6, C8, C15, C23, C32, and C34 owing to their connection to nitrogen or oxygen atoms. These findings suggest that the N and O atoms are the preferred sites for protonation. C32 isthe most positively charged atom, while N33 is the most negatively charged one. On the other hand, C35 possesses the lowest negative charge, as compared with the other carbon atom in the phenyl moiety owing to its connection to the chlorine atom.

3.6. Frontier Molecular Orbital Analysis

The kinetic stability and chemical reactivity of a molecule could be examined through the energy gap between its HOMO (highest occupied molecular orbital) and its LUMO (lowest unoccupied molecular orbital) [32]. The B3LYP/6-311++G(d,p) level of theory was utilized to calculate the energy gap for the semicarbazone 4 and Figure 5 illustrates the graphical representation of its frontier molecular orbitals. The electron distribution is scattered in HOMO over the benzodioxole ring, the hydrazinecarboxamide moiety, and is slightly upon the chlorophenyl ring, whereas the LUMO is mainly disseminated over the benzodioxole fragment. The electron density is transferred in the HOMO→LUMO transition from the chlorophenyl fragment to the benzodioxole moiety through the hydrazine carboxamide bridge. This transition illustrates the charge transfer from the electron-donor functionalities to electron-acceptor fragments via a π-conjugated path. The FMO (frontier molecular orbital) energy gap of the semicarbazone 4 was found to be 4.23 eV (HOMO energy = −6.007 eV, LUMO energy = −1.777 eV). This energy gap leads to charge transfer within the semicarbazone 4, which could promote its bioactivity.

3.7. Molecular Docking Simulations

Gaussian 09 program was used to optimize the structure of the semicarbazones 4 with the aid of the density functional theory using [26]. AutoDock Tools-1.5.4 implemented in MGL Tools-1.5.4 package was harnessed to carry out molecular docking investigations [33]. The fungal RNA Kinase (PDB ID: 5U32) target protein was chosento perform the current docking analysis [34]. The three-dimensional (3D) coordinates file of 5U32 with a resolution of 2.27 Å was secured from RCSB (Research Collaboratory for Structural Bioinformatics) protein data bank [35]. Affinity grids centered on the active site with 126×126×126 grid size with a spacing of 0.42 Å were generated with the aid of AutoGrid 4.2 [36]. The docking procedure was carried out as described in the literature [21]. The docking results were examined through sorting the binding free energy envisaged by the docked confirmations of the semicarbazone 4. The presaged best confirmation binding energy was −4.02 kcal/mol. The amino acids PHE436, LEU608, ASP607, and LYS610 in the active site of the target protein binds with the ligand by hydrogen bonding with bond lengths of 1.83 and 2.26 as well as 2.04, 2.27, and 1.92, respectively. The protein-ligand interaction complex is given in Figure 6, suggesting the possible binding mode of the title compound 4 to the target protein 5U32.

3.8. Hirshfeld Surface Analysis

The Hirshfeld surfaces and their associated 2D fingerprint plots for the title compound 4 were computed, taking single crystal X-ray crystal structure as input. The Hirshfeld surface emerged from an attempt to define the space occupied by a molecule in a crystal for the purpose of partitioning the crystal electron density into molecular fragments [37]. It provides a 3D picture of close contacts in a crystal, and these contacts can be summarized in a fingerprint plot [38]. For each point on the Hirshfeld surface, two distances are defined, namely the de: the distance from a point to the nearest nucleus external to the surface and the di: the distance to the nearest nucleus internal to the surface. A plot of di versus de is a 2D fingerprint plot which recognizes the existence of different types of intermolecular interactions. The Hirshfeld surfaces of the title compound are given in Figure 7 and it explains the surfaces that have been mapped over dnorm, de, and di and curvedness (3D plots).
The function dnorm (normalized chemical contacts) is a ratio encompassing the distances of any surface point to the nearest di and de atom and the van der Waals radii of the atoms. The value of dnorm may be positive or negative depending on whether the intermolecular contacts being either longer or shorter than the van der Waals separations. The negative value of dnorm indicates the sum of di and de is shorter than the sum of the relevant van der Waals radii, which is considered to be the closest contact and is visualized as red color in the Hirshfeld surfaces. The blue color denotes contacts longer than the sum of van der Waals radii with positive dnorm values, whereas contacts close to van der Waalsradiiwith dnorm equal to zero are colored white. The intermolecular interactions outwards the H...H/NH/CH/OH bonds as well as the overall fingerprint region of the title molecule are displayed in Figure 8. With these analyses, the division of contributions is possible for different interactions including HH, NH, CH, and OH, which commonly overlap in the full finger print plots. Figure 7 shows the dnorm surface of the semicarbazone 4, highlighting only HH/NH intermolecular contacts. These interactions comprise 35.5% and 5.7% of the total Hirshfeld surface area for this molecule, respectively. OH/NH intermolecular interactions are represented by a two sharp spike in the 2D fingerprint plot (Figure 8). The relative contributions of the CH and OH contacts are 12.2% and 7.5%, respectively.

3.9. Antifungal Activity of the Semicarbazone 4

Table 6 illustrates the minimum inhibitory concentrations (MICs) values of the antifungal profile of the target semicarbazone 4, as well as the reference standard antifungal drugs, fluconazole, and ketoconazole. The best antifungal activity of the semicarbazone 4 was displayed against C. albicans with MIC value of 0.156 μmol/mL.

4. Conclusions

(2E)-2-[1-(1,3-Benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-N-(2-chlorophenyl)hydrazinecarboxamide (4) has been synthesized and identified with different spectroscopic techniques. The assigned chemical structure of the title compound 4 as well as the (E)-configuration of its imine functionality were unambiguously assured using single crystal X-ray analysis.
The optimized geometry of the semicarbazone 4 revealed that the predicted values are consistent with the experimental results with few exceptions that are insignificant. The obtained theoretical model of the title compound 4 by DFT calculations describes the possibility of C–HN intramolecular hydrogen bonding and ICT charge transfer interactions that stabilize its structure. These results were further confirmed via NBO and NPA analyses on the title compound 4. Frontier molecular orbital analysis also confirmed the presence of intramolecular charge transfer within the title molecule 4, leading to its stability and henceits bioactivity. Hirshfeld surface analysis revealed the occurrence of strong and weak intermolecular interactions in the crystalline state of the semicarbazone 4 like O...H, C...H and N...H bonding. The in vitro antifungal potential of the title compound 4 was examined against different fungal strains and the best activity was manifested against C. albicans with MIC value of 0.156 μmol/mL. A molecular docking study suggested the anticipated binding mode of the title compound 4 to its target protein. The results of the current study inspired us to design new antifungal candidates bearing the scaffold of the title compound 4 with the hope of getting more potent antifungal drug-like surrogates with better antifungal profile.

Supplementary Materials

The following are available online at https://www.mdpi.com/2073-4352/9/2/82/s1, Figure S1: Correlation plot for calculated and experimental bond lengths of semicarbazone 4; Figure S2: 1H NMR spectrum of the semicarbazone 4; Figure S3: Enlarged part of the 1H NMR spectrum of the semicarbazone 4; Figure S4:13C NMR spectrum of the semicarbazone 4.

Author Contributions

R.I.A.-W. and A.R.A.-G. synthesized and characterized the title molecule. H.A.G. conducted X-ray analysis. M.H.A.-A. conducted the antifungal profiling. S.A.V.A. and I.H.J. performed the computational work. M.I.A. conceptualized the work and prepared the manuscript for publication. All authors discussed the contents of the manuscript.

Funding

The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group Project no. RGP-196.

Conflicts of Interest

The authors have declared that there is no conflict of interests.

References

  1. Crunkhorn, S. Fungal infection: Protecting from Candida albicans. Nat. Rev. Drug Discov. 2016, 15, 604. [Google Scholar] [CrossRef] [PubMed]
  2. Vandeputte, P.; Ferrari, S.; Coste, A.T. Antifungal resistance and new strategies to control fungal infections. Int. J. Microbiol. 2011, 2012, 713687. [Google Scholar] [CrossRef] [PubMed]
  3. Wu, J.; Ni, T.; Chai, X.; Wang, T.; Wang, H.; Chen, J.; Jin, Y.; Zhang, D.; Yu, S.; Jiang, Y. Molecular docking, design, synthesis and antifungal activity study of novel triazole derivatives. Eur. J. Med. Chem. 2018, 143, 1840–1846. [Google Scholar] [CrossRef] [PubMed]
  4. Lino, C.I.; de Souza, I.G.; Borelli, B.M.; Matos, T.T.S.; Teixeira, I.N.S.; Ramos, J.P.; de Souza Fagundes, E.M.; de Oliveira Fernandes, P.; Maltarollo, V.G.; Johann, S. Synthesis, molecular modeling studies and evaluation of antifungal activity of a novel series of thiazole derivatives. Eur. J. Med. Chem. 2018, 151, 248–260. [Google Scholar] [CrossRef] [PubMed]
  5. Sanglard, D. Emerging threats in antifungal-resistant fungal pathogens. Front. Med. 2016, 3, 11. [Google Scholar] [CrossRef] [PubMed]
  6. Pappas, P.G.; Kauffman, C.A.; Andes, D.R.; Clancy, C.J.; Marr, K.A.; Ostrosky-Zeichner, L.; Reboli, A.C.; Schuster, M.G.; Vazquez, J.A.; Walsh, T.J. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2015, 62, e1–e50. [Google Scholar] [CrossRef]
  7. Aoyama, Y.; Yoshida, Y.; Sato, R. Yeast cytochrome P-450 catalyzing lanosterol 14 alpha-demethylation. II. Lanosterol metabolism by purified P-450 (14) DM and by intact microsomes. J. Biol. Chem. 1984, 259, 1661–1666. [Google Scholar]
  8. Aboul-Enein, M.N.; El-Azzouny, A.A.; Attia, M.I.; Saleh, O.A.; Kansoh, A.L. Synthesis and anti-Candida potential of certain novel 1-[(3-substituted-3-phenyl)propyl]-1H-imidazoles. Arch. Pharm. 2011, 344, 794–801. [Google Scholar] [CrossRef]
  9. Roman, G.; Mares, M.; Nastasa, V. A novel antifungal agent with broad spectrum: 1-(4-biphenylyl)-3-(1H-imidazol-1-yl)-1-propanone. Arch. Pharm. 2013, 346, 110–118. [Google Scholar] [CrossRef]
  10. Attia, M.I.; Radwan, A.A.; Zakaria, A.S.; Almutairi, M.S.; Ghoneim, S.W. 1-Aryl-3-(1H-imidazol-1-yl)propan-1-ol esters: Synthesis, anti-Candida potential and molecular modeling studies. Chem. Cent. J. 2013, 7, 168. [Google Scholar] [CrossRef]
  11. Venkatachalam, T.K.; Bernhardt, P.V.; Noble, C.J.; Fletcher, N.; Pierens, G.K.; Thurecht, K.J.; Reutens, D.C. Synthesis, characterization and biological activities of semicarbazones and their copper complexes. J. Inorg. Biochem. 2016, 162, 295–308. [Google Scholar] [CrossRef] [PubMed]
  12. Beraldo, H.; Gambino, D. The wide pharmacological versatility of semicarbazones, thiosemicarbazones and their metal complexes. Mini Rev. Med. Chem. 2004, 4, 31–39. [Google Scholar] [PubMed]
  13. Jafri, L.; Ansari, F.L.; Jamil, M.; Kalsoom, S.; Qureishi, S.; Mirza, B. Microwave-assisted synthesis and bioevaluation of some semicarbazones. Chem. Biol. Drug Des. 2012, 79, 950–959. [Google Scholar] [CrossRef] [PubMed]
  14. Laly, S.; Parameswaran, G. Synthesis and characterisation of some thiosemicarbazone complexes of Ag (I), Pt (II) and Pd (II). Asian J. Chem. 1993, 5, 712–718. [Google Scholar]
  15. Aboul-Enein, M.N.; El-Azzouny, A.A.; Attia, M.I.; Maklad, Y.A.; Amin, K.M.; Abdel-Rehim, M.; El-Behairy, M.F. Design and synthesis of novel stiripentol analogues as potential anticonvulsants. Eur. J. Med. Chem. 2012, 47, 360–369. [Google Scholar] [CrossRef] [PubMed]
  16. Leite, A.C.L.; da Silva, K.P.; de Souza, I.A.; de Araújo, J.M.; Brondani, D.J. Synthesis, antitumour and antimicrobial activities of new peptidyl derivatives containing the 1,3-benzodioxole system. Eur. J. Med. Chem. 2004, 39, 1059–1065. [Google Scholar] [CrossRef] [PubMed]
  17. Attia, M.I.; El-Brollosy, N.R.; Kansoh, A.L.; Ghabbour, H.A.; Al-Wabli, R.I.; Fun, H.-K. Synthesis, single crystal X-ray structure, and antimicrobial activity of 6-(1,3-benzodioxol -5-ylmethyl)-5-ethyl-2-{[2-(morpholin-4-yl)ethyl]sulfanyl}pyrimidin-4(3H)-one. J. Chem. 2014, 2014, 457430. [Google Scholar] [CrossRef]
  18. Attia, M.I.; Zakaria, A.S.; Almutairi, M.S.; Ghoneim, S.W. In vitro anti-Candida activity of certain new 3-(1H-imidazol-1-yl)propan-1-one oxime esters. Molecules 2013, 18, 12208–12221. [Google Scholar] [CrossRef] [PubMed]
  19. Al-Wabli, R.I.; Al-Ghamdi, A.R.; Ghabbour, H.A.; Al-Agamy, M.H.; Monicka, J.C.; Joe, I.H.; Attia, M.I. Synthesis, X-ray single crystal structure, molecular docking and DFT computations on N-[(1E)-1-(2H-1,3-benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-hydroxylamine: A new potential antifungal agent precursor. Molecules 2017, 22, 373. [Google Scholar] [CrossRef]
  20. Al-Wabli, R.I.; Al-Ghamdi, A.R.; Ghabbour, H.A.; Al-Agamy, M.H.; Attia, M.I. Synthesis, single crystal X-ray analysis, and antifungal profiling of certain new oximino ethers bearing imidazole nuclei. Molecules 2017, 22, 1895. [Google Scholar] [CrossRef]
  21. Al-Wabli, R.I.; Al-Ghamdi, A.R.; Primsa, I.; Ghabbour, H.A.; Al-Agamy, M.H.; Joe, I.H.; Attia, M.I. (2E)-2-[1-(1,3-benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-N-(4-methoxyphenyl)hydrazine carboxamide: Synthesis, crystal structure, vibrational analysis, DFT computations, molecular docking and antifungal activity. J. Mol. Struct. 2018, 1166, 121–130. [Google Scholar] [CrossRef]
  22. Al-Wabli, R.I.; Al-Ghamdi, A.R.; Ghabbour, H.A.; Al-Agamy, M.H.; Attia, M.I. Synthesis and spectroscopic identification of certain imidazole-semicarbazone conjugates bearing benzodioxole moieties: New antifungal agents. Molecules 2019, 24, 200. [Google Scholar] [CrossRef] [PubMed]
  23. Beukers, M.W.; Wanner, M.J.; Von Frijtag Drabbe Künzel, J.K.; Klaasse, E.C.; Ijzerman, A.P.; Koomen, G.-J. N-6-Cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor. J. Med. Chem. 2003, 46, 1492–1503. [Google Scholar] [CrossRef] [PubMed]
  24. Sheldrick, G.M. A short history of SHELX. Acta Cryst. A 2008, 64, 112–122. [Google Scholar] [CrossRef] [PubMed]
  25. Becke, A.D. Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 1993, 98, 5648–5652. [Google Scholar] [CrossRef]
  26. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A.; et al. Gaussian-09; Revision A.02; Gaussian, Inc.: Wallingford, CT, USA, 2009. [Google Scholar]
  27. Jamróz, M.H. Vibrational energy distribution analysis (VEDA): Scopes and limitations. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2013, 114, 220–230. [Google Scholar] [CrossRef] [PubMed]
  28. Wolff, S.; Grimwood, D.; McKinnon, J.; Jayatilaka, D.; Spackman, M. Crystal Explorer 2.0; University of Western Australia: Perth, Australia, 2007. [Google Scholar]
  29. Reed, A.E.; Curtiss, L.A.; Weinhold, F. Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint. Chem. Rev. 1988, 88, 899–926. [Google Scholar] [CrossRef]
  30. Allen, F.H.; Kennard, O.; Watson, D.G.; Brammer, L.; Orpen, A.G.; Taylor, R. Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds. J. Chem. Soc. Perkin Trans. 2 1987, S1–S19. [Google Scholar] [CrossRef]
  31. Reed, A.E.; Weinstock, R.B.; Weinhold, F. Natural population analysis. J. Chem. Phys. 1985, 83, 735–746. [Google Scholar] [CrossRef]
  32. Fleming, I. Frontier Orbitals and Organic Chemical Reactions; Wiley: Hoboken, NJ, USA, 1977. [Google Scholar]
  33. Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comp. Chem. 2009, 30, 2785–2791. [Google Scholar] [CrossRef] [Green Version]
  34. Bonanno, J.B.; Edo, C.; Eswar, N.; Pieper, U.; Romanowski, M.J.; Ilyin, V.; Gerchman, S.E.; Kycia, H.; Studier, F.W.; Sali, A. Structural genomics of enzymes involved in sterol/isoprenoid biosynthesis. Proc. Natl. Acad. Sci. USA 2001, 98, 12896–12901. [Google Scholar] [CrossRef] [PubMed]
  35. Bernstein, F.C.; Koetzle, T.F.; Williams, G.J.; Meyer, E.F., Jr.; Brice, M.D.; Rodgers, J.R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. The protein data bank: A computer-based archival file for macromolecular structures. Arch. Biochem. Biophys. 1978, 185, 584–591. [Google Scholar] [CrossRef]
  36. Morris, G.M.; Goodsell, D.S.; Halliday, R.S.; Huey, R.; Hart, W.E.; Belew, R.K.; Olson, A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comp. Chem. 1998, 19, 1639–1662. [Google Scholar] [CrossRef] [Green Version]
  37. Spackman, M.A.; Byrom, P.G. A novel definition of a molecule in a crystal. Chem. Phys. Lett. 1997, 267, 215–220. [Google Scholar] [CrossRef]
  38. Spackman, M.A.; Jayatilaka, D. Hirshfeld surface analysis. Cryst. Eng. Comm. 2009, 11, 19–32. [Google Scholar] [CrossRef]
Scheme 1. Synthesis of the target semicarbazone 4. Reagents and conditions: (i) HN(CH3)2·HCl, (CH2O)n, conc. HCl, ethanol, reflux, 2 h; (ii) Imidazole, water, reflux, 5 h; (iii) N-(2-Chlorophenyl)hydrazinecarboxamide, ethanol, acetic acid, rt, 18 h.
Scheme 1. Synthesis of the target semicarbazone 4. Reagents and conditions: (i) HN(CH3)2·HCl, (CH2O)n, conc. HCl, ethanol, reflux, 2 h; (ii) Imidazole, water, reflux, 5 h; (iii) N-(2-Chlorophenyl)hydrazinecarboxamide, ethanol, acetic acid, rt, 18 h.
Crystals 09 00082 sch001
Figure 1. Oak ridge thermal ellipsoid plot diagram of the semicarbazones 4 drawn at 50% ellipsoids for non-hydrogen atoms.
Figure 1. Oak ridge thermal ellipsoid plot diagram of the semicarbazones 4 drawn at 50% ellipsoids for non-hydrogen atoms.
Crystals 09 00082 g001
Figure 2. Molecular packing of the semicarbazone 4 manifesting hydrogen bonds which are drawn as dashed lines.
Figure 2. Molecular packing of the semicarbazone 4 manifesting hydrogen bonds which are drawn as dashed lines.
Crystals 09 00082 g002
Figure 3. Atom numbering scheme of optimized semicarbazone 4 structure.
Figure 3. Atom numbering scheme of optimized semicarbazone 4 structure.
Crystals 09 00082 g003
Figure 4. Charge distribution on the atoms of the semicarbazone 4.
Figure 4. Charge distribution on the atoms of the semicarbazone 4.
Crystals 09 00082 g004
Figure 5. Frontier molecular orbitals of the semicarbazone 4.
Figure 5. Frontier molecular orbitals of the semicarbazone 4.
Crystals 09 00082 g005
Figure 6. Pose of the semicarbazone 4 with the amino acid residues of the target protein.
Figure 6. Pose of the semicarbazone 4 with the amino acid residues of the target protein.
Crystals 09 00082 g006
Figure 7. Hirshfeld surfaces for dnorm, di, and de and curvedness for thesemicarbazone 4.
Figure 7. Hirshfeld surfaces for dnorm, di, and de and curvedness for thesemicarbazone 4.
Crystals 09 00082 g007
Figure 8. Two dimension finger print plots showing various intermolecular contacts in thesemicarbazones 4.
Figure 8. Two dimension finger print plots showing various intermolecular contacts in thesemicarbazones 4.
Crystals 09 00082 g008
Table 1. X-ray experimental details of the semicarbazone 4.
Table 1. X-ray experimental details of the semicarbazone 4.
Crystal Data
Molecular formulaC20H18ClN5O3
Mr411.84
Crystal system, space groupMonoclinic, P21/c
Temperature (K)293
a, b, c (Å)8.7780 (6), 20.5417 (15), 11.0793 (9)
β (°)100.774 (2)
V3)1962.5 (3)
Z4
Radiation typeMo Kα
µ (mm−1)0.23
Crystal size (mm3)0.33 × 0.19 × 0.11
Data Collection
DiffractometerBrucker APEX-II D8 venture diffractometer
Absorption correctionMulti-scanSADABS Bruker 2014
Tmin, Tmax0.954, 0.962
No. of measured, independent and observed [I> 2σ(I)] reflections28076, 4511, 2424
Rint0.095
Refinement
R[F2> 2σ( F2)], wR(F2), S0.060, 0.137, 1.04
No. of reflections4511
No. of parameters270
No. of restraints0
H-atom treatmentH atoms treated by a mixture of independent and constrained refinement
Δρmax, Δρmin (e Å−3)0.18, −0.29
Table 2. Geometric parameters (Å, °) of the semicarbazone 4.
Table 2. Geometric parameters (Å, °) of the semicarbazone 4.
AtomBond Length/AngleAtomBond Length/Angle
Cl44–C351.736 (3)N22–C261.359 (3)
O7–C61.377 (3)N24–C231.300 (4)
O7–C81.416 (3)N24–C251.350 (4)
O9–C11.372 (3)N30–N311.378 (3)
O9–C81.422 (4)N30–C151.288 (3)
O46–C321.224 (3)N31–C321.360 (3)
N22–C191.454 (3)N33–C321.361 (3)
N22–C231.351 (3)N33–C341.403 (3)
C6–O7–C8105.8 (2)N30–C15–C4116.0 (2)
C1–O9–C8105.4 (2)N30–C15–C16123.5 (2)
C19–N22–C23126.9 (2)N22–C19–C16114.3 (2)
C19–N22–C26127.8 (2)N22–C23–N24112.9 (3)
C23–N22–C26105.3 (2)N24–C25–C26111.2 (3)
C23–N24–C25104.3 (3)N22–C26–C25106.4 (2)
N31–N30–C15119.1 (2)N31–C32–N33114.8 (2)
N30–N31–C32119.4 (2)O46–C32–N31120.6 (2)
C32–N33–C34127.9 (2)O46–C32–N33124.6 (3)
O7–C6–C1109.2 (2)N33–C34–C39124.1 (3)
O7–C6–C5128.4 (2)N33–C34–C35118.4 (2)
O9–C1–C2128.8 (3)Cl44–C35–C34119.5 (2)
O9–C1–C6109.9 (2)Cl44–C35–C36118.8 (2)
O7–C8–O9107.5 (2)
Table 3. Hydrogen-bond geometry (Å) of the semicarbazone 4.
Table 3. Hydrogen-bond geometry (Å) of the semicarbazone 4.
D–H···AD–HH···AD···AD–H···A
N31–H4N31···O46i0.85(3)2.06(3)2.896(3)169(3)
C16–H17B···O46i0.97002.51003.207(3)129.00
C23–H29A···O9ii0.93002.45003.301(4)152.00
C26–H27A···N24iii0.93002.49003.326(4)150.00
C39–H40A···O460.93002.30002.886(4)121.00
Symmetry codes: (i) −x−2, −y−1, −z−1; (ii) x−1, y, z; (iii) x, −y−3/2, z−1/2.
Table 4. Selected optimized parameters for the semicarbazone 4.
Table 4. Selected optimized parameters for the semicarbazone 4.
ParametersDFTExp.ParametersDFTExp.
Bond lengths\ÅDihedral Angles\°
C1–C21.37511.356C5–C4–C15–N30–0.51–1.54
C1–C61.39541.371C3–C4–C15–N30179.97178.01
C2–C31.40531.392C15–N30–N31–C32174.78176.1
C2–H101.08220.931N30–N31–C32–N33–174.29–2.89
C3–C41.40111.378N32–C32–N33–C34–178.49176.6
C3–H111.08160.931C32–N33–C34–C39–1.04–1.54
C4–C51.41891.378C32–N33–C34–C35179.15165.48
C4–C151.48521.480C4–C15–C16–C19–88.51101.58
C5–C61.37011.359C15–C16–C19–N22–175.16–76.52
C5–H121.08110.930C16–C19–N22–C26–73.22–78.94
C15=N301.28891.2881C16–C19–N22–C23103.09101.11
N30–N311.35241.3781Bond Angles\°
C32–N311.40421.378C5–C4–C15121.79121.74
C32–N331.38751.402C3–C4–C15118.89119.62
C34–N331.40161.362C3–C4–C5119.33122.40
C34–C351.40721.396N33–C34–C35118.58118.36
C34–C391.40351.389N33–C34–C39123.84124.08
C35–C361.38731.378C35–C34–C39117.58117.56
C36–C371.39181.368
C37–C381.39251.370
C38–C391.39081.380
C39–C341.40351.389
Table 5. Second-order perturbation theory analysis of Fock matrix in NBO basis for the semicarbazone 4.
Table 5. Second-order perturbation theory analysis of Fock matrix in NBO basis for the semicarbazone 4.
Donor (i)Acceptor (j)E(2) a kcal/molE(j)-E(i) b (a.u.)F(i,j) c (a.u.)
NBOOccupancyNBOOccupancy
σ(C1–C2)1.97467σ*(C1–C6)0.039684.481.270.068
σ(C1–C2)1.97467σ*(C1–O9)0.028533.660.340.032
σ(C1–C2)1.97467σ*(C1–O7)0.032531.471.070.035
σ (C1–C6)1.97447σ*(C1–C2)0.020654.651.350.071
σ (C1–C6)1.97447σ*(C15–N30)0.016221.510.760.032
σ (C1-O9)1.98708σ*(C35–Cl44)0.033890.533.490.039
σ(C2–H10)1.97906σ*(C37–H42)0.013190.580.790.019
σ(C3–C4)1.97383σ*(C1–O9)0.0285312.750.310.056
σ(C3–C4)1.97383σ*(C2–C3)0.020656.450.170.078
σ(C3–C4)1.97383σ*(N24–C25)0.0108338.230.180.074
π(C3–C4)1.69506π*(C1–C2)0.020650.563.680.041
π(C3–C4)1.69506π*(C25–H28)0.0169133.364.070.356
π(C5–C6)1.70385π*(C1–C2)0.0206514.570.470.075
π(C5–C6)1.70385π*(C34–C35)0.464820.660.450.016
n1(N30)1.90915σ*(C5–H12)0.014014.400.820.055
n1(N33)1.70147σ*(N31–C32)0.0892213.150.460.069
a: E(2) means energy of stabilization interactions; b: Energy difference between donor-to-acceptor, i and j NBO orbitals; c: F(i,j) is the Fock matrix element between i and j NBO orbitals.
Table 6. The minimum inhibitory concentrations (MICs) values for the antifungal activity of the semicarbazone 4, fluconazole and ketoconazole towards Aspergillus niger and various Candida species.
Table 6. The minimum inhibitory concentrations (MICs) values for the antifungal activity of the semicarbazone 4, fluconazole and ketoconazole towards Aspergillus niger and various Candida species.
Compound No.MIC (μmol/mL)
C. albicansC. tropicalisC.parapsilosisAspergillus niger
40.156> 1.240.3110.622
Fluconazole0.0510.0450.047ND
KetoconazoleNDNDND0.02
ND: not determined.

Share and Cite

MDPI and ACS Style

Al-Wabli, R.I.; Al-Ghamdi, A.R.; Aswathy, S.A.V.; Ghabbour, H.A.; Al-Agamy, M.H.; Hubert Joe, I.; Attia, M.I. (2E)-2-[1-(1,3-Benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-N-(2-chlorophenyl)hydrazine carboxamide: Synthesis, X-ray Structure, Hirshfeld Surface Analysis, DFT Calculations, Molecular Docking and Antifungal Profile. Crystals 2019, 9, 82. https://doi.org/10.3390/cryst9020082

AMA Style

Al-Wabli RI, Al-Ghamdi AR, Aswathy SAV, Ghabbour HA, Al-Agamy MH, Hubert Joe I, Attia MI. (2E)-2-[1-(1,3-Benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-N-(2-chlorophenyl)hydrazine carboxamide: Synthesis, X-ray Structure, Hirshfeld Surface Analysis, DFT Calculations, Molecular Docking and Antifungal Profile. Crystals. 2019; 9(2):82. https://doi.org/10.3390/cryst9020082

Chicago/Turabian Style

Al-Wabli, Reem I., Alwah R. Al-Ghamdi, Suchindra Amma Vijayakumar Aswathy, Hazem A. Ghabbour, Mohamed H. Al-Agamy, Issac Hubert Joe, and Mohamed I. Attia. 2019. "(2E)-2-[1-(1,3-Benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-N-(2-chlorophenyl)hydrazine carboxamide: Synthesis, X-ray Structure, Hirshfeld Surface Analysis, DFT Calculations, Molecular Docking and Antifungal Profile" Crystals 9, no. 2: 82. https://doi.org/10.3390/cryst9020082

APA Style

Al-Wabli, R. I., Al-Ghamdi, A. R., Aswathy, S. A. V., Ghabbour, H. A., Al-Agamy, M. H., Hubert Joe, I., & Attia, M. I. (2019). (2E)-2-[1-(1,3-Benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propylidene]-N-(2-chlorophenyl)hydrazine carboxamide: Synthesis, X-ray Structure, Hirshfeld Surface Analysis, DFT Calculations, Molecular Docking and Antifungal Profile. Crystals, 9(2), 82. https://doi.org/10.3390/cryst9020082

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop